5COLUCCI W S, ELKAYAM E, HORTON D P, et al. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure[J]. N Engl J Med,2000,18(343) :246-253.
6KAWAKAMI R, SAITO Y, KISHIMOTO I, et al. Overexpression of brain natriuretic peptide facilitates neutrophil infiltration and cardiac matrix metalloproteinase-9 expression after acute myocardial infarction[J]. Circulaion, 2004,110 (21 ) : 3306-3312.
7Sagnella GA.Mearement and significance of circulating natriuretic peptides in cardiovascular disease.Clin Sci,1998,95:519-529.
8Hystad ME,Geiran OR,Attramadal H,et al.Regional cardiac expression and concentration of natriuretic peptides in patients with severe chronic heart failure.Acta Physiol Scand,2001,171:395-403.
9Goto T,Takase H,Toriyama T,et al.Circulating concentrations of cardiac proteins indicate the severity of congestive heart failure.Heart,2003,89:1303-1307.
10Hobbs RE,Miller LW,Bott-Silverman C,et al.Hemodynamic effects of a single Intravenous Injection of synthetic human brain natriuretic peptide in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.Am J Cardiol,1996,78:896
